Structure-activity relationship for enantiomers of potent inhibitors of B. anthracis dihydrofolate reductase.
Bourne, C.R., Wakeham, N., Nammalwar, B., Tseitin, V., Bourne, P.C., Barrow, E.W., Mylvaganam, S., Ramnarayan, K., Bunce, R.A., Berlin, K.D., Barrow, W.W.(2013) Biochim Biophys Acta 1834: 46-52
- PubMed: 22999981 
- DOI: https://doi.org/10.1016/j.bbapap.2012.09.001
- Primary Citation of Related Structures:  
4ELB, 4ELE, 4ELF, 4ELG, 4ELH - PubMed Abstract: 
Bacterial resistance to antibiotic therapies is increasing and new treatment options are badly needed. There is an overlap between these resistant bacteria and organisms classified as likely bioterror weapons. For example, Bacillus anthracis is innately resistant to the anti-folate trimethoprim due to sequence changes found in the dihydrofolate reductase enzyme. Development of new inhibitors provides an opportunity to enhance the current arsenal of anti-folate antibiotics while also expanding the coverage of the anti-folate class.
Organizational Affiliation: 
Department of Veterinary Pathobiology, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK 74078, USA. christina.bourne@okstate.edu